Kerecis Fish Skin Grafts

Advanced acellular dermal matrix technology from Atlantic cod skin to promote superior wound healing outcomes

What is Kerecis?

Ocean-Derived Innovation in Wound Care

Kerecis pioneered the use of intact Atlantic cod fish skin from Iceland as an advanced acellular dermal matrix scaffold for superior wound management and tissue regeneration.

🐟

Fish Skin as a Biological Framework

Unlike mammalian-derived grafts, Kerecis products are derived from intact Atlantic cod fish skin harvested from sustainable fisheries in Iceland. The gentle decellularization process preserves the natural three-dimensional architecture of collagen, elastin, and glycosaminoglycans—creating a true extracellular matrix that promotes rapid cellular ingrowth and neovascularization.

  • Acellular dermal matrix scaffold promotes cellular infiltration
  • High concentration of omega-3 polyunsaturated fatty acids (EPA and DHA)
  • Natural antimicrobial and anti-inflammatory properties
  • FDA-cleared for use since 2013, now part of Coloplast
  • Maintains structural integrity while promoting vascularization
Kerecis is now part of Coloplast, a global leader in medical devices and healthcare solutions, ensuring product quality, regulatory compliance, and continued innovation in advanced wound care.
Mechanism of Action

How Fish Skin Promotes Healing

Kerecis works through multiple biological pathways to accelerate wound closure and tissue quality.

🏗️

Structural Scaffold

Acts as a three-dimensional acellular dermal matrix that provides architectural support for host cell infiltration, collagen deposition, and vascular network formation.

💊

Anti-Inflammatory Pathway

Omega-3 polyunsaturated fatty acids (DHA and EPA) activate specialized pro-resolving mediator (SPM) pathways that reduce IL-1β production from macrophages, decreasing inflammation while promoting healing.

🩸

Rapid Neovascularization

The natural porosity and bioactive properties of fish skin stimulate rapid blood vessel formation, restoring oxygen and nutrient delivery to wounded tissues.

🛡️

Natural Microbial Barrier

Provides an immediate protective barrier against contamination and infection while the wound transitions from the inflammatory to proliferative phase.

Product Lines

Kerecis Solutions for Every Wound Type

Five specialized product lines engineered for specific clinical indications and wound characteristics.

🌊
Chronic Wounds

Kerecis MariGen

Flagship product for chronic wound management including diabetic foot ulcers, venous leg ulcers, and pressure ulcers.

Variants: Solid, Micro, Fenestrated, Expanse

🔧
Surgical Wounds

Kerecis SurgiClose

Specialized for surgical and trauma wounds including post-Mohs wounds, donor sites, and surgical defects.

Variants: Standard, Silicone, Micro, Meshed 2:1

🔥
Burn Wounds

Kerecis GraftGuide

Optimized for burn wound management including second-degree and full-thickness burns with enhanced scar quality outcomes.

Variants: Solid, Micro, Mano (hand-shaped), Meshed 2:1

🦶
Diabetic Foot

Kerecis Shield

Specifically designed for diabetic foot ulcers with integrated silicone contact layer to reduce pain and optimize moisture management.

Variants: Standard, Adhesive, Spiral

💪
Soft Tissue

Kerecis SurgiBind

For soft tissue reinforcement, tendon protection, and complex surgical reconstructions requiring structural support.

Application: Soft tissue barrier and protection

Clinical Evidence

Peer-Reviewed Research Supporting Kerecis

Recent published studies demonstrate superior healing outcomes and safety profiles across multiple wound types.

Diabetic Foot Ulcers

Dardari et al. (2025) demonstrated 41.6% complete wound closure with Kerecis MariGen at 16 weeks in diabetic foot ulcers, compared to 22.2% with standard care—an 87% improvement in healing outcomes in the Diabetes & Metabolism journal.
Dardari et al., 2025. Diabetes & Metabolism. Complete wound closure comparison: MariGen 41.6% vs. Standard Care 22.2% at 16 weeks
Tan & Chng (2025) reported 100% healing rate in 6 diabetic foot ulcer patients when Kerecis MariGen was combined with negative pressure wound therapy (NPWT) in the Cureus journal, demonstrating synergistic treatment approaches.
Tan & Chng, 2025. Cureus. Six DFU patients achieved 100% healing using combined Kerecis + NPWT protocol

Ischemic and Complex Wounds

Lee et al. (2024) demonstrated 82% healing success in ischemic wounds treated with Kerecis compared to 45% with standard care in the Journal of Wound Care, highlighting effectiveness in difficult-to-heal ischemic tissues.
Lee et al., 2024. Journal of Wound Care. Ischemic wound healing: Kerecis 82% vs. Standard Care 45% success rates

Burn Wound Management

Heitzmann et al. (2026) published data in the Journal of Burn Care Research showing superior scar quality at 12 months post-injury in patients treated with Kerecis GraftGuide compared to Suprathel, a commonly used synthetic alternative.
Heitzmann et al., 2026. Journal of Burn Care Research. Scar quality outcomes favoring Kerecis GraftGuide over Suprathel at 12-month follow-up
Heitzmann et al. (2025) found that Kerecis GraftGuide reduced healing time to 17 days compared to 23 days with alternative burn treatments in the Burns journal, representing 26% faster healing trajectories.
Heitzmann et al., 2025. Burns. Kerecis-treated burns healed in 17 days vs. 23 days for standard burn care

Safety and Infection Control

Ivana & Sanjaya (2025) systematically reviewed infection rates across 114 patients in 6 different studies using Kerecis products in the European Burn Journal, documenting only 1 infection case across the entire cohort—a 0.88% infection rate demonstrating excellent antimicrobial barrier properties.
Ivana & Sanjaya, 2025. European Burn Journal. Systematic review of 114 patients: only 1 infection (0.88% rate) documented across 6 studies

Biocompatibility and Immunogenicity

Magnusson et al. (2018) demonstrated in the International Journal of Lower Extremity Wounds that Kerecis fish skin showed no autoimmune response in recipients and demonstrated superior biocompatibility compared to porcine-derived acellular dermal matrices, supporting its use in immunocompromised patients.
Magnusson et al., 2018. International Journal of Lower Extremity Wounds. Fish skin vs. porcine: superior immunogenicity profile with no autoimmune response
Clinical Indications

Comprehensive Wound Type Coverage

Kerecis products are indicated for a wide spectrum of acute and chronic wounds.

Wound Category Specific Indications Recommended Product Line
Chronic Wounds Diabetic foot ulcers, venous leg ulcers, pressure ulcers, stasis ulcers MariGen (primary), Shield (DFU specific)
Surgical Wounds Donor sites, post-Mohs micrographic surgery defects, podiatric surgery, trauma lacerations SurgiClose, SurgiBind
Partial & Full-Thickness Partial-thickness wounds, full-thickness skin defects MariGen (chronic), SurgiClose (acute)
Burn Wounds Second-degree (partial-thickness) burns, full-thickness burns, thermal injuries GraftGuide (primary burn treatment)
Trauma & Acute Wounds Abrasions, skin tears, puncture wounds, laceration repair SurgiClose, MariGen
Tendon & Soft Tissue Tendon injuries, soft tissue reinforcement, surgical reconstruction SurgiBind
Complex Wounds Ischemic wounds, infected wounds (post-cleansing), refractory wounds MariGen with adjunctive therapy
Competitive Advantages

Why Choose Fish Skin Over Alternatives?

Kerecis offers distinct biological and clinical advantages compared to mammalian grafts and synthetic alternatives.

Fish Skin vs. Mammalian Grafts

  • Omega-3 Content: Fish skin contains naturally high concentrations of EPA and DHA that mammalian grafts lack, providing inherent anti-inflammatory benefits
  • Biocompatibility: Fish-derived products show no autoimmune response (Magnusson et al., 2018), making them superior for immunocompromised patients
  • Structural Integrity: Iceland sourcing ensures consistent quality and preservation of native collagen and elastin architecture
  • Infection Control: Natural antimicrobial properties reduce infection rates to 0.88% across large patient cohorts
  • Regulatory Status: FDA-cleared since 2013 with extensive clinical validation and published evidence base

Fish Skin vs. Synthetic Alternatives

  • Biological Activity: Unlike inert synthetics, fish skin actively promotes cellular ingrowth and vascularization through native bioactive compounds
  • Healing Speed: Burns treated with fish skin heal 26% faster (17 days vs. 23 days) compared to synthetic alternatives
  • Scar Quality: Superior long-term cosmetic outcomes with better scar quality at 12 months versus Suprathel and other synthetics
  • Multi-Mechanism: Combines structural support, anti-inflammatory signaling, and antimicrobial protection—synthetics typically address only one mechanism
  • Natural Porosity: Enables faster neovascularization and oxygen exchange versus polymer-based materials
Frequently Asked Questions

Common Questions About Kerecis

Kerecis uses a proprietary gentle decellularization process on Atlantic cod fish skin harvested from sustainable fisheries in Iceland. The process removes all cellular components while preserving the native three-dimensional extracellular matrix architecture, including collagen, elastin, and glycosaminoglycans. This preservation of natural structure is critical to the product's biological activity and the retention of omega-3 polyunsaturated fatty acids (EPA and DHA). The intact matrix provides superior scaffolding for cellular infiltration and neovascularization compared to other acellular dermal matrices.

This is an important consideration that should be discussed with the treating clinician. The decellularization process removes cellular proteins that typically trigger allergic responses. However, patients with severe fish allergies should inform their healthcare provider before treatment. The risk of systemic allergic reaction is minimal since the product is applied topically to the wound rather than ingested, and the decellularization removes allergen-containing cells. Your wound care specialist can assess individual risk factors and determine appropriate precautions or alternative treatments if needed.

Application depends on the specific wound type and product variant. Generally, Kerecis products are applied directly to a clean, debrided wound bed. For chronic wounds like diabetic foot ulcers, MariGen or Shield is placed on the prepared wound surface, often with appropriate wound dressing coverage to maintain a moist healing environment. For burns and surgical wounds, the tissue is placed as a graft covering. Some variants come with silicone contact layers (Shield, SurgiClose Silicone) that remain adherent to the wound, while others are integrated into dressings. Your wound care specialist will determine the specific application protocol based on your wound characteristics and clinical situation. Detailed application instructions accompany each product box.

Kerecis products are supplied either as fresh or ready-to-use formulations with varying shelf lives based on the specific product variant. Fresh products typically have 21-day shelf life when stored in specialized preservative solutions at specific temperature ranges (typically 2-8°C). Ready-to-use products may have extended shelf life. Storage conditions are critical to maintaining product viability and therapeutic properties. Detailed storage instructions and shelf life information are provided with each product. Always check packaging for specific storage requirements and expiration dates. Proper storage maintains the structural integrity and bioactive properties of the fish skin matrix.

Kerecis products have FDA clearance as acellular dermal matrices and are covered by most major insurance plans, including Medicare and Medicaid, for appropriate clinical indications. Coverage determination depends on factors including diagnosis, wound characteristics, evidence of standard care failure or contraindications, medical necessity documentation, and specific insurance plan policies. Your healthcare provider's office typically handles insurance verification and pre-authorization when needed. Coverage may vary by specific product variant and clinical indication. Sunspot Medical Group can assist with insurance questions and can help facilitate the authorization process for patients in our service area. We recommend contacting your insurance provider or our office for specific coverage details.

Key Benefits Summary

Why Clinicians Choose Kerecis

📊 Superior Efficacy

41.6% healing in DFUs vs. 22.2% standard care. 82% success in ischemic wounds. 100% healing when combined with NPWT.

⚡ Faster Healing

26% faster burn healing (17 days vs. 23 days). Rapid neovascularization through natural porosity.

🛡️ Excellent Safety

0.88% infection rate across 114 patients. No autoimmune response. FDA-cleared since 2013.

🎯 Bioactive

Natural omega-3 fatty acids activate anti-inflammatory pathways. Multi-mechanism action beyond passive scaffolding.

🌍 Sustainable

Atlantic cod fish skin from sustainable Icelandic fisheries. Environmentally responsible sourcing.

💼 Well-Covered

FDA-cleared acellular dermal matrix covered by Medicare, Medicaid, and most insurance plans.

Ready to Learn More About Kerecis?

Contact Sunspot Medical Group in Las Cruces, NM to discuss Kerecis products for your patients or facility.

Request Product Information
⚠️

Patient Disclaimer: Kerecis fish skin grafts and acellular dermal matrices are prescription medical devices that should only be used under the direction of a qualified healthcare provider. The information on this page is for educational purposes and does not constitute medical advice. Individual suitability, appropriate use, contraindications, and safety considerations vary by patient and should be thoroughly discussed with your healthcare provider. Clinical outcomes depend on proper application technique, appropriate wound selection, patient factors, and comprehensive wound care management. Please consult your healthcare provider to determine if Kerecis products are appropriate for your specific condition.

Get In Touch

Request Kerecis Product Information

Healthcare providers and facilities in Las Cruces and surrounding areas can contact us for product samples, ordering information, and clinical support.